Sushmita Chatterjee - Publications

Affiliations: 
2016- Dept. of Cell Research & Immunology, The Center for Nanoscience and Nanotechnology Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Yong SB, Ramishetti S, Goldsmith M, Diesendruck Y, Hazan-Halevy I, Chatterjee S, Gonna SN, Ezra A, Peer D. Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of Cancer. Advanced Materials (Deerfield Beach, Fla.). e2106350. PMID 35044699 DOI: 10.1002/adma.202106350  0.303
2021 Singh MS, Ramishetti S, Landesman-Milo D, Goldsmith M, Chatterjee S, Palakuri R, Peer D. Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer. Small (Weinheim An Der Bergstrasse, Germany). e2100287. PMID 33825318 DOI: 10.1002/smll.202100287  0.358
2019 Rathod M, Chatterjee S, Dutta S, Kalraiya R, Bhattacharya D, De A. Mannose glycosylation is an integral step for human NIS localization and function in breast cancer cells. Journal of Cell Science. PMID 31455607 DOI: 10.1242/jcs.232058  0.654
2017 Kelkar MG, Thakur B, Derle A, Chatterjee S, Ray P, De A. Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer. Breast Cancer Research and Treatment. PMID 28528452 DOI: 10.1007/s10549-017-4297-2  0.573
2015 Chatterjee S, Thaker N, De A. Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells. Breast Cancer (Dove Medical Press). 7: 251-65. PMID 26355636 DOI: 10.2147/BCTT.S84648  0.617
2015 Chatterjee S, Thaker N, De A. Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells Breast Cancer: Targets and Therapy. 7: 251-265. DOI: 10.2147/BCTT.S84648  0.63
2014 Chatterjee S, De A. Applications of lentiviral vectors in molecular imaging. Frontiers in Bioscience (Landmark Edition). 19: 835-53. PMID 24896320 DOI: 10.2741/4251  0.561
2013 Shete H, Chatterjee S, De A, Patravale V. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies. International Journal of Pharmaceutics. 454: 584-92. PMID 23535344 DOI: 10.1016/j.ijpharm.2013.03.036  0.627
2013 Chatterjee S, Malhotra R, Varghese F, Bukhari AB, Patil A, Budrukkar A, Parmar V, Gupta S, De A. Quantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer. Plos One. 8: e54055. PMID 23342072 DOI: 10.1371/Journal.Pone.0054055  0.686
Show low-probability matches.